An inactivated bacterium (paraprobiotic) expressing Bacillus thuringiensis Cry5B as a therapeutic for Ascaris and Parascaris spp. infections in large animals
Ascaris and Parascaris are important parasites in the family Ascarididae, large, ubiquitous intestinal-dwelling nematodes infecting all classes of vertebrates. Parasitic nematode drug resistance in veterinary medicine and drug recalcitrance in human medicine are increasing worldwide, with few if any...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-06-01
|
Series: | One Health |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352771421000318 |
id |
doaj-e5782bf3588046cc9a30cb10373a4552 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Joseph F. Urban, Jr Martin K. Nielsen David Gazzola Yue Xie Ethiopia Beshah Yan Hu Hanchen Li Florentina Rus Kelly Flanagan Austin Draper Sridhar Vakalapudi Robert W. Li Gary R. Ostroff Raffi V. Aroian |
spellingShingle |
Joseph F. Urban, Jr Martin K. Nielsen David Gazzola Yue Xie Ethiopia Beshah Yan Hu Hanchen Li Florentina Rus Kelly Flanagan Austin Draper Sridhar Vakalapudi Robert W. Li Gary R. Ostroff Raffi V. Aroian An inactivated bacterium (paraprobiotic) expressing Bacillus thuringiensis Cry5B as a therapeutic for Ascaris and Parascaris spp. infections in large animals One Health Ascaris Parascaris Anthelmintic Paraprobiotic Bacillus thuringiensis Cry5B crystal protein |
author_facet |
Joseph F. Urban, Jr Martin K. Nielsen David Gazzola Yue Xie Ethiopia Beshah Yan Hu Hanchen Li Florentina Rus Kelly Flanagan Austin Draper Sridhar Vakalapudi Robert W. Li Gary R. Ostroff Raffi V. Aroian |
author_sort |
Joseph F. Urban, Jr |
title |
An inactivated bacterium (paraprobiotic) expressing Bacillus thuringiensis Cry5B as a therapeutic for Ascaris and Parascaris spp. infections in large animals |
title_short |
An inactivated bacterium (paraprobiotic) expressing Bacillus thuringiensis Cry5B as a therapeutic for Ascaris and Parascaris spp. infections in large animals |
title_full |
An inactivated bacterium (paraprobiotic) expressing Bacillus thuringiensis Cry5B as a therapeutic for Ascaris and Parascaris spp. infections in large animals |
title_fullStr |
An inactivated bacterium (paraprobiotic) expressing Bacillus thuringiensis Cry5B as a therapeutic for Ascaris and Parascaris spp. infections in large animals |
title_full_unstemmed |
An inactivated bacterium (paraprobiotic) expressing Bacillus thuringiensis Cry5B as a therapeutic for Ascaris and Parascaris spp. infections in large animals |
title_sort |
inactivated bacterium (paraprobiotic) expressing bacillus thuringiensis cry5b as a therapeutic for ascaris and parascaris spp. infections in large animals |
publisher |
Elsevier |
series |
One Health |
issn |
2352-7714 |
publishDate |
2021-06-01 |
description |
Ascaris and Parascaris are important parasites in the family Ascarididae, large, ubiquitous intestinal-dwelling nematodes infecting all classes of vertebrates. Parasitic nematode drug resistance in veterinary medicine and drug recalcitrance in human medicine are increasing worldwide, with few if any new therapeutic classes on the horizon. Some of these parasites are zoonotic, e.g., Ascaris is passed from humans to pigs and vice versa. The development of new therapies against this family of parasites would have major implications for both human and livestock health. Here we tested the therapeutic ability of a paraprobiotic or dead probiotic that expresses the Bacillus thuringiensis Cry5B protein with known anthelmintic properties, against zoonotic Ascaris suum and Parascaris spp. This paraprobiotic, known as IBaCC, intoxicated A. suum larvae in vitro and was highly effective in vivo against intestinal A. suum infections in a new mouse model for this parasite. Fermentation was scaled up to 350 l to treat pigs and horses. Single dose Cry5B IBaCC nearly completely cleared A. suum infections in pigs. Furthermore, single dose Cry5B IBaCC drove fecal egg counts in Parascaris-infected foals to zero, showing at least parity with, and potential superiority to, current efficacy of anthelmintics used against this parasite. Cry5B IBaCC therefore represents a new, paraprobiotic One Health approach towards targeting Ascarididae that is safe, effective, massively scalable, stable, and useful in human and veterinary medicine in both the developed and developing regions of the world. |
topic |
Ascaris Parascaris Anthelmintic Paraprobiotic Bacillus thuringiensis Cry5B crystal protein |
url |
http://www.sciencedirect.com/science/article/pii/S2352771421000318 |
work_keys_str_mv |
AT josephfurbanjr aninactivatedbacteriumparaprobioticexpressingbacillusthuringiensiscry5basatherapeuticforascarisandparascarissppinfectionsinlargeanimals AT martinknielsen aninactivatedbacteriumparaprobioticexpressingbacillusthuringiensiscry5basatherapeuticforascarisandparascarissppinfectionsinlargeanimals AT davidgazzola aninactivatedbacteriumparaprobioticexpressingbacillusthuringiensiscry5basatherapeuticforascarisandparascarissppinfectionsinlargeanimals AT yuexie aninactivatedbacteriumparaprobioticexpressingbacillusthuringiensiscry5basatherapeuticforascarisandparascarissppinfectionsinlargeanimals AT ethiopiabeshah aninactivatedbacteriumparaprobioticexpressingbacillusthuringiensiscry5basatherapeuticforascarisandparascarissppinfectionsinlargeanimals AT yanhu aninactivatedbacteriumparaprobioticexpressingbacillusthuringiensiscry5basatherapeuticforascarisandparascarissppinfectionsinlargeanimals AT hanchenli aninactivatedbacteriumparaprobioticexpressingbacillusthuringiensiscry5basatherapeuticforascarisandparascarissppinfectionsinlargeanimals AT florentinarus aninactivatedbacteriumparaprobioticexpressingbacillusthuringiensiscry5basatherapeuticforascarisandparascarissppinfectionsinlargeanimals AT kellyflanagan aninactivatedbacteriumparaprobioticexpressingbacillusthuringiensiscry5basatherapeuticforascarisandparascarissppinfectionsinlargeanimals AT austindraper aninactivatedbacteriumparaprobioticexpressingbacillusthuringiensiscry5basatherapeuticforascarisandparascarissppinfectionsinlargeanimals AT sridharvakalapudi aninactivatedbacteriumparaprobioticexpressingbacillusthuringiensiscry5basatherapeuticforascarisandparascarissppinfectionsinlargeanimals AT robertwli aninactivatedbacteriumparaprobioticexpressingbacillusthuringiensiscry5basatherapeuticforascarisandparascarissppinfectionsinlargeanimals AT garyrostroff aninactivatedbacteriumparaprobioticexpressingbacillusthuringiensiscry5basatherapeuticforascarisandparascarissppinfectionsinlargeanimals AT raffivaroian aninactivatedbacteriumparaprobioticexpressingbacillusthuringiensiscry5basatherapeuticforascarisandparascarissppinfectionsinlargeanimals AT josephfurbanjr inactivatedbacteriumparaprobioticexpressingbacillusthuringiensiscry5basatherapeuticforascarisandparascarissppinfectionsinlargeanimals AT martinknielsen inactivatedbacteriumparaprobioticexpressingbacillusthuringiensiscry5basatherapeuticforascarisandparascarissppinfectionsinlargeanimals AT davidgazzola inactivatedbacteriumparaprobioticexpressingbacillusthuringiensiscry5basatherapeuticforascarisandparascarissppinfectionsinlargeanimals AT yuexie inactivatedbacteriumparaprobioticexpressingbacillusthuringiensiscry5basatherapeuticforascarisandparascarissppinfectionsinlargeanimals AT ethiopiabeshah inactivatedbacteriumparaprobioticexpressingbacillusthuringiensiscry5basatherapeuticforascarisandparascarissppinfectionsinlargeanimals AT yanhu inactivatedbacteriumparaprobioticexpressingbacillusthuringiensiscry5basatherapeuticforascarisandparascarissppinfectionsinlargeanimals AT hanchenli inactivatedbacteriumparaprobioticexpressingbacillusthuringiensiscry5basatherapeuticforascarisandparascarissppinfectionsinlargeanimals AT florentinarus inactivatedbacteriumparaprobioticexpressingbacillusthuringiensiscry5basatherapeuticforascarisandparascarissppinfectionsinlargeanimals AT kellyflanagan inactivatedbacteriumparaprobioticexpressingbacillusthuringiensiscry5basatherapeuticforascarisandparascarissppinfectionsinlargeanimals AT austindraper inactivatedbacteriumparaprobioticexpressingbacillusthuringiensiscry5basatherapeuticforascarisandparascarissppinfectionsinlargeanimals AT sridharvakalapudi inactivatedbacteriumparaprobioticexpressingbacillusthuringiensiscry5basatherapeuticforascarisandparascarissppinfectionsinlargeanimals AT robertwli inactivatedbacteriumparaprobioticexpressingbacillusthuringiensiscry5basatherapeuticforascarisandparascarissppinfectionsinlargeanimals AT garyrostroff inactivatedbacteriumparaprobioticexpressingbacillusthuringiensiscry5basatherapeuticforascarisandparascarissppinfectionsinlargeanimals AT raffivaroian inactivatedbacteriumparaprobioticexpressingbacillusthuringiensiscry5basatherapeuticforascarisandparascarissppinfectionsinlargeanimals |
_version_ |
1721507870839668736 |
spelling |
doaj-e5782bf3588046cc9a30cb10373a45522021-04-26T05:57:15ZengElsevierOne Health2352-77142021-06-0112100241An inactivated bacterium (paraprobiotic) expressing Bacillus thuringiensis Cry5B as a therapeutic for Ascaris and Parascaris spp. infections in large animalsJoseph F. Urban, Jr0Martin K. Nielsen1David Gazzola2Yue Xie3Ethiopia Beshah4Yan Hu5Hanchen Li6Florentina Rus7Kelly Flanagan8Austin Draper9Sridhar Vakalapudi10Robert W. Li11Gary R. Ostroff12Raffi V. Aroian13U. S. Department of Agriculture, Agricultural Research Service, Beltsville Agricultural Research Center, Animal and Parasitic Diseases Laboratory, Beltsville, MD, United States of America; U. S. Department of Agriculture, Agricultural Research Service, Beltsville Human Nutrition Research Center, Diet, Genomics and Immunology Laboratory, Beltsville, MD, United States of America; Corresponding author at: U. S. Department of Agriculture, Agricultural Research Service, Beltsville Agricultural Research Center, Animal and Parasitic Diseases Laboratory, Beltsville, MD, United States of America.M.H. Gluck Equine Research Center, Department of Veterinary Science, University of Kentucky, Lexington, KY, United States of AmericaProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, United States of AmericaU. S. Department of Agriculture, Agricultural Research Service, Beltsville Agricultural Research Center, Animal and Parasitic Diseases Laboratory, Beltsville, MD, United States of America; U. S. Department of Agriculture, Agricultural Research Service, Beltsville Human Nutrition Research Center, Diet, Genomics and Immunology Laboratory, Beltsville, MD, United States of America; Department of Parasitology, College of Veterinary Medicine, Sichuan Agricultural University, Sichuan, ChinaU. S. Department of Agriculture, Agricultural Research Service, Beltsville Agricultural Research Center, Animal and Parasitic Diseases Laboratory, Beltsville, MD, United States of America; U. S. Department of Agriculture, Agricultural Research Service, Beltsville Human Nutrition Research Center, Diet, Genomics and Immunology Laboratory, Beltsville, MD, United States of AmericaProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, United States of AmericaProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, United States of AmericaProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, United States of AmericaProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, United States of AmericaSynthetic Biomanufacturing Facility, Utah State University, Logan, UT, United States of AmericaSynthetic Biomanufacturing Facility, Utah State University, Logan, UT, United States of AmericaU. S. Department of Agriculture, Agricultural Research Service, Beltsville Agricultural Research Center, Animal and Parasitic Diseases Laboratory, Beltsville, MD, United States of AmericaProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, United States of AmericaProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, United States of America; Corresponding author.Ascaris and Parascaris are important parasites in the family Ascarididae, large, ubiquitous intestinal-dwelling nematodes infecting all classes of vertebrates. Parasitic nematode drug resistance in veterinary medicine and drug recalcitrance in human medicine are increasing worldwide, with few if any new therapeutic classes on the horizon. Some of these parasites are zoonotic, e.g., Ascaris is passed from humans to pigs and vice versa. The development of new therapies against this family of parasites would have major implications for both human and livestock health. Here we tested the therapeutic ability of a paraprobiotic or dead probiotic that expresses the Bacillus thuringiensis Cry5B protein with known anthelmintic properties, against zoonotic Ascaris suum and Parascaris spp. This paraprobiotic, known as IBaCC, intoxicated A. suum larvae in vitro and was highly effective in vivo against intestinal A. suum infections in a new mouse model for this parasite. Fermentation was scaled up to 350 l to treat pigs and horses. Single dose Cry5B IBaCC nearly completely cleared A. suum infections in pigs. Furthermore, single dose Cry5B IBaCC drove fecal egg counts in Parascaris-infected foals to zero, showing at least parity with, and potential superiority to, current efficacy of anthelmintics used against this parasite. Cry5B IBaCC therefore represents a new, paraprobiotic One Health approach towards targeting Ascarididae that is safe, effective, massively scalable, stable, and useful in human and veterinary medicine in both the developed and developing regions of the world.http://www.sciencedirect.com/science/article/pii/S2352771421000318AscarisParascarisAnthelminticParaprobioticBacillus thuringiensisCry5B crystal protein |